nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Upset stomach—Metformin—metabolic syndrome X	0.0625	0.0816	CcSEcCtD
Apraclonidine—Rhinorrhoea—Metformin—metabolic syndrome X	0.0506	0.066	CcSEcCtD
Apraclonidine—Nasopharyngitis—Metformin—metabolic syndrome X	0.0266	0.0347	CcSEcCtD
Apraclonidine—Abdominal discomfort—Metformin—metabolic syndrome X	0.0246	0.0322	CcSEcCtD
Apraclonidine—Infestation NOS—Metformin—metabolic syndrome X	0.0229	0.0299	CcSEcCtD
Apraclonidine—Infestation—Metformin—metabolic syndrome X	0.0229	0.0299	CcSEcCtD
Apraclonidine—Bradycardia—Metformin—metabolic syndrome X	0.0209	0.0273	CcSEcCtD
Apraclonidine—Rhinitis—Metformin—metabolic syndrome X	0.0206	0.0269	CcSEcCtD
Apraclonidine—Oedema peripheral—Metformin—metabolic syndrome X	0.0203	0.0264	CcSEcCtD
Apraclonidine—Eye disorder—Metformin—metabolic syndrome X	0.0192	0.0251	CcSEcCtD
Apraclonidine—Angiopathy—Metformin—metabolic syndrome X	0.0187	0.0244	CcSEcCtD
Apraclonidine—Mediastinal disorder—Metformin—metabolic syndrome X	0.0185	0.0242	CcSEcCtD
Apraclonidine—Erythema—Metformin—metabolic syndrome X	0.0179	0.0234	CcSEcCtD
Apraclonidine—Dysgeusia—Metformin—metabolic syndrome X	0.0175	0.0229	CcSEcCtD
Apraclonidine—Vision blurred—Metformin—metabolic syndrome X	0.0169	0.022	CcSEcCtD
Apraclonidine—Ill-defined disorder—Metformin—metabolic syndrome X	0.0166	0.0217	CcSEcCtD
Apraclonidine—Malaise—Metformin—metabolic syndrome X	0.0162	0.0211	CcSEcCtD
Apraclonidine—Syncope—Metformin—metabolic syndrome X	0.0161	0.021	CcSEcCtD
Apraclonidine—Palpitations—Metformin—metabolic syndrome X	0.0158	0.0207	CcSEcCtD
Apraclonidine—Myalgia—Metformin—metabolic syndrome X	0.0153	0.0199	CcSEcCtD
Apraclonidine—Chest pain—Metformin—metabolic syndrome X	0.0153	0.0199	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0151	0.0198	CcSEcCtD
Apraclonidine—Discomfort—Metformin—metabolic syndrome X	0.0151	0.0197	CcSEcCtD
Apraclonidine—Oedema—Metformin—metabolic syndrome X	0.0146	0.0191	CcSEcCtD
Apraclonidine—Infection—Metformin—metabolic syndrome X	0.0145	0.0189	CcSEcCtD
Apraclonidine—Nervous system disorder—Metformin—metabolic syndrome X	0.0143	0.0187	CcSEcCtD
Apraclonidine—Skin disorder—Metformin—metabolic syndrome X	0.0142	0.0185	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.0133	0.0174	CcSEcCtD
Apraclonidine—Paraesthesia—Metformin—metabolic syndrome X	0.0131	0.0171	CcSEcCtD
Apraclonidine—Dyspnoea—Metformin—metabolic syndrome X	0.013	0.017	CcSEcCtD
Apraclonidine—Somnolence—Metformin—metabolic syndrome X	0.013	0.017	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.0126	0.0165	CcSEcCtD
Apraclonidine—Fatigue—Metformin—metabolic syndrome X	0.0126	0.0164	CcSEcCtD
Apraclonidine—Constipation—Metformin—metabolic syndrome X	0.0125	0.0163	CcSEcCtD
Apraclonidine—Feeling abnormal—Metformin—metabolic syndrome X	0.012	0.0157	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.012	0.0156	CcSEcCtD
Apraclonidine—Abdominal pain—Metformin—metabolic syndrome X	0.0116	0.0151	CcSEcCtD
Apraclonidine—Asthenia—Metformin—metabolic syndrome X	0.0105	0.0137	CcSEcCtD
Apraclonidine—Pruritus—Metformin—metabolic syndrome X	0.0103	0.0135	CcSEcCtD
Apraclonidine—Diarrhoea—Metformin—metabolic syndrome X	0.01	0.0131	CcSEcCtD
Apraclonidine—Dizziness—Metformin—metabolic syndrome X	0.00967	0.0126	CcSEcCtD
Apraclonidine—Vomiting—Metformin—metabolic syndrome X	0.0093	0.0121	CcSEcCtD
Apraclonidine—Dermatitis—Metformin—metabolic syndrome X	0.00921	0.012	CcSEcCtD
Apraclonidine—Headache—Metformin—metabolic syndrome X	0.00916	0.0119	CcSEcCtD
Apraclonidine—Nausea—Metformin—metabolic syndrome X	0.00868	0.0113	CcSEcCtD
Apraclonidine—ADRA2C—Metabolism—APOA5—metabolic syndrome X	0.000363	0.00156	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—GHRL—metabolic syndrome X	0.000362	0.00155	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—HSD11B1—metabolic syndrome X	0.000362	0.00155	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—CCL2—metabolic syndrome X	0.000357	0.00153	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—AGT—metabolic syndrome X	0.000352	0.00151	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—CD36—metabolic syndrome X	0.00035	0.0015	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000349	0.00149	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HDAC3—metabolic syndrome X	0.000347	0.00149	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CNR1—metabolic syndrome X	0.000343	0.00147	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000342	0.00146	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—TRIB3—metabolic syndrome X	0.000338	0.00145	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—IGF1—metabolic syndrome X	0.000336	0.00144	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000334	0.00143	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00033	0.00141	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HDAC3—metabolic syndrome X	0.000324	0.00139	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000324	0.00139	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—G6PD—metabolic syndrome X	0.000323	0.00138	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—SERPINE1—metabolic syndrome X	0.000319	0.00137	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—ALB—metabolic syndrome X	0.000319	0.00136	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—GHRL—metabolic syndrome X	0.000317	0.00136	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—HDAC3—metabolic syndrome X	0.000315	0.00135	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—IGF1—metabolic syndrome X	0.000314	0.00134	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000314	0.00134	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CCL2—metabolic syndrome X	0.000312	0.00134	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00031	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00031	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GCKR—metabolic syndrome X	0.000308	0.00132	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—LPA—metabolic syndrome X	0.000308	0.00132	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000307	0.00131	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—APOA1—metabolic syndrome X	0.000305	0.00131	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—NOS3—metabolic syndrome X	0.000305	0.0013	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—NAMPT—metabolic syndrome X	0.000303	0.0013	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000302	0.0013	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—RBP4—metabolic syndrome X	0.000302	0.0013	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—LIPC—metabolic syndrome X	0.000301	0.00129	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GCK—metabolic syndrome X	0.000301	0.00129	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CNR1—metabolic syndrome X	0.0003	0.00128	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—APOC3—metabolic syndrome X	0.000299	0.00128	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PLA2G6—metabolic syndrome X	0.000298	0.00128	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—SERPINE1—metabolic syndrome X	0.000298	0.00128	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—ALB—metabolic syndrome X	0.000298	0.00127	CbGpPWpGaD
Apraclonidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	0.000297	0.00127	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—APOA5—metabolic syndrome X	0.000295	0.00126	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—GHRL—metabolic syndrome X	0.000294	0.00126	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000293	0.00125	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CETP—metabolic syndrome X	0.00029	0.00124	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CCL2—metabolic syndrome X	0.00029	0.00124	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00029	0.00124	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCL5—metabolic syndrome X	0.000285	0.00122	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—NOS3—metabolic syndrome X	0.000285	0.00122	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000284	0.00121	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000283	0.00121	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—RBP4—metabolic syndrome X	0.000282	0.00121	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TRIB3—metabolic syndrome X	0.000282	0.00121	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CNR1—metabolic syndrome X	0.000279	0.00119	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—SCARB1—metabolic syndrome X	0.000278	0.00119	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—TRIB3—metabolic syndrome X	0.000274	0.00118	CbGpPWpGaD
Apraclonidine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	0.000272	0.00116	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—SREBF1—metabolic syndrome X	0.00027	0.00116	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—APOC3—metabolic syndrome X	0.000268	0.00115	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL5—metabolic syndrome X	0.000266	0.00114	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000265	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000263	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—HMGCR—metabolic syndrome X	0.000263	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GOT2—metabolic syndrome X	0.000263	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—AGT—metabolic syndrome X	0.000262	0.00112	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000256	0.0011	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IGF1—metabolic syndrome X	0.000255	0.00109	CbGpPWpGaD
Apraclonidine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	0.000254	0.00109	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000253	0.00109	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—APOC3—metabolic syndrome X	0.00025	0.00107	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000247	0.00106	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—RBP4—metabolic syndrome X	0.000247	0.00106	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—NAMPT—metabolic syndrome X	0.000246	0.00105	CbGpPWpGaD
Apraclonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000246	0.00105	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—AGT—metabolic syndrome X	0.000245	0.00105	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—LIPC—metabolic syndrome X	0.000245	0.00105	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GCK—metabolic syndrome X	0.000245	0.00105	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—APOC3—metabolic syndrome X	0.000243	0.00104	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—SERPINE1—metabolic syndrome X	0.000242	0.00104	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000242	0.00104	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—ALB—metabolic syndrome X	0.000242	0.00104	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—AGT—metabolic syndrome X	0.000238	0.00102	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000238	0.00102	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CETP—metabolic syndrome X	0.000236	0.00101	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000235	0.00101	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ABCA1—metabolic syndrome X	0.000234	0.001	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—SLC2A4—metabolic syndrome X	0.000234	0.001	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CYBA—metabolic syndrome X	0.000234	0.001	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000233	0.000996	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000232	0.000992	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—NOS3—metabolic syndrome X	0.000231	0.00099	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000229	0.000983	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—RBP4—metabolic syndrome X	0.000229	0.000983	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—GHRL—metabolic syndrome X	0.000229	0.000982	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GOT1—metabolic syndrome X	0.000227	0.000971	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GGT1—metabolic syndrome X	0.000227	0.000971	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—SCARB1—metabolic syndrome X	0.000226	0.000968	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR2C—metabolic syndrome X	0.000226	0.000967	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—AGT—metabolic syndrome X	0.000222	0.000953	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—SREBF1—metabolic syndrome X	0.000219	0.00094	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—APOC3—metabolic syndrome X	0.000219	0.000937	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CYBA—metabolic syndrome X	0.000219	0.000937	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CNR1—metabolic syndrome X	0.000217	0.00093	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000216	0.000925	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000215	0.000922	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000214	0.000917	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GHRL—metabolic syndrome X	0.000214	0.000917	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GOT2—metabolic syndrome X	0.000213	0.000914	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—HMGCR—metabolic syndrome X	0.000213	0.000914	CbGpPWpGaD
Apraclonidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	0.000206	0.000883	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—APOC3—metabolic syndrome X	0.000203	0.00087	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CNR1—metabolic syndrome X	0.000203	0.000868	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—TGFB1—metabolic syndrome X	0.000201	0.000863	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000199	0.000852	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000197	0.000845	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000196	0.00084	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—AGT—metabolic syndrome X	0.000195	0.000833	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—APOB—metabolic syndrome X	0.000192	0.000824	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CYBA—metabolic syndrome X	0.000191	0.000819	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ABCA1—metabolic syndrome X	0.00019	0.000815	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—SLC2A4—metabolic syndrome X	0.00019	0.000815	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—TGFB1—metabolic syndrome X	0.000188	0.000806	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PLA2G4A—metabolic syndrome X	0.000187	0.000802	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GHRL—metabolic syndrome X	0.000187	0.000802	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GGT1—metabolic syndrome X	0.000184	0.000789	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GOT1—metabolic syndrome X	0.000184	0.000789	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—LPL—metabolic syndrome X	0.000184	0.000787	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000183	0.000786	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL2—metabolic syndrome X	0.000183	0.000785	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—AGT—metabolic syndrome X	0.000181	0.000774	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CYBA—metabolic syndrome X	0.000178	0.000761	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IGF2—metabolic syndrome X	0.000177	0.00076	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CNR1—metabolic syndrome X	0.000177	0.000759	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CD36—metabolic syndrome X	0.000175	0.000748	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GHRL—metabolic syndrome X	0.000174	0.000745	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—APOB—metabolic syndrome X	0.000172	0.000738	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL5—metabolic syndrome X	0.000168	0.00072	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000168	0.000718	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IGF2—metabolic syndrome X	0.000166	0.00071	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CNR1—metabolic syndrome X	0.000165	0.000705	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—LPL—metabolic syndrome X	0.000164	0.000704	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PPARA—metabolic syndrome X	0.000162	0.000695	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—APOB—metabolic syndrome X	0.000161	0.000689	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.00016	0.000686	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—AGT—metabolic syndrome X	0.000157	0.000673	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL5—metabolic syndrome X	0.000157	0.000673	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000157	0.00067	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—APOB—metabolic syndrome X	0.000156	0.000669	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—APOE—metabolic syndrome X	0.000154	0.00066	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—LPL—metabolic syndrome X	0.000154	0.000658	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	0.000153	0.000655	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—APOA1—metabolic syndrome X	0.000152	0.000652	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	0.000152	0.000651	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—LPL—metabolic syndrome X	0.000149	0.000639	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000149	0.000637	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	0.000145	0.000621	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CD36—metabolic syndrome X	0.000142	0.000607	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—AGT—metabolic syndrome X	0.000141	0.000603	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	0.000141	0.000602	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—AKT1—metabolic syndrome X	0.00014	0.0006	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—APOE—metabolic syndrome X	0.000138	0.00059	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—LEP—metabolic syndrome X	0.000138	0.00059	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	0.000137	0.000588	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000137	0.000586	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—APOA1—metabolic syndrome X	0.000136	0.000584	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	0.000135	0.000577	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	0.000134	0.000575	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PPARG—metabolic syndrome X	0.000134	0.000575	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PPARA—metabolic syndrome X	0.000132	0.000565	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—INS—metabolic syndrome X	0.000132	0.000564	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—AGT—metabolic syndrome X	0.000131	0.000563	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—AKT1—metabolic syndrome X	0.000131	0.00056	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	0.000131	0.00056	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—APOE—metabolic syndrome X	0.000129	0.000552	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—LEP—metabolic syndrome X	0.000129	0.000552	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—AGT—metabolic syndrome X	0.000128	0.000547	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	0.000128	0.000547	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—APOA1—metabolic syndrome X	0.000127	0.000545	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000127	0.000545	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—APOE—metabolic syndrome X	0.000125	0.000536	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	0.000125	0.000534	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—APOA1—metabolic syndrome X	0.000124	0.00053	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	0.000123	0.000527	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ALB—metabolic syndrome X	0.000121	0.000517	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	0.000118	0.000504	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	0.000116	0.000496	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—NOS3—metabolic syndrome X	0.000115	0.000494	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	0.000115	0.000492	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	0.000115	0.000492	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	0.000114	0.000488	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	0.000113	0.000482	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	0.000113	0.000482	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	0.000111	0.000477	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	0.00011	0.000471	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	0.000109	0.000467	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	0.000108	0.000464	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000108	0.000463	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—INS—metabolic syndrome X	0.000107	0.000458	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	0.000107	0.000457	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	0.000106	0.000456	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	0.000106	0.000455	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	0.000106	0.000452	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	0.000105	0.000448	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	0.000105	0.000448	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	0.000103	0.000443	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	0.000103	0.000442	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000101	0.000433	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	0.0001	0.00043	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ALB—metabolic syndrome X	9.8e-05	0.00042	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	9.65e-05	0.000413	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	9.62e-05	0.000412	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	9.46e-05	0.000405	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	9.37e-05	0.000401	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	9.33e-05	0.0004	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	9.3e-05	0.000398	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	8.94e-05	0.000383	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	8.85e-05	0.000379	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.83e-05	0.000378	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	8.79e-05	0.000377	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	8.71e-05	0.000373	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	8.64e-05	0.00037	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	8.57e-05	0.000367	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	8.43e-05	0.000361	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8.27e-05	0.000354	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.21e-05	0.000352	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	8.14e-05	0.000349	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	8.04e-05	0.000344	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	7.84e-05	0.000336	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.51e-05	0.000322	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.23e-05	0.00031	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	7.11e-05	0.000305	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	6.83e-05	0.000293	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.72e-05	0.000288	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	6.61e-05	0.000283	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.56e-05	0.000281	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.38e-05	0.000273	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.1e-05	0.000261	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.58e-05	0.000239	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—AKT1—metabolic syndrome X	5.3e-05	0.000227	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.18e-05	0.000222	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	5.15e-05	0.00022	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	4.81e-05	0.000206	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	4.75e-05	0.000203	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	4.44e-05	0.00019	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.31e-05	0.000185	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.2e-05	0.00018	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	3.9e-05	0.000167	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.88e-05	0.000166	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.6e-05	0.000154	CbGpPWpGaD
